Hyperglycemia induced by glucocorticoids in nondiabetic patients: A meta-analysis

Annals of Nutrition and Metabolism

Volumn 65, Issue 4, 2014, Pages 324-332

  Liu, Xiao Xia ^a   Zhu, Xiao Ming ^b   Miao, Qing ^a   Ye, Hong Ying ^b   Zhang, Zhao Yun ^b   Li, Yi Ming ^b  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

Diabetes; Glucocorticoid; Glucocorticoid induced hyperglycemia; Hyperglycemia; Steroids

Indexed keywords

GLUCOCORTICOID; PREDNISOLONE;

ARTICLE; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DRUG INDUCED DISEASE; DRUG SAFETY; HUMAN; HYPERGLYCEMIA; META ANALYSIS; SYSTEMATIC REVIEW; TREATMENT OUTCOME; CHEMICALLY INDUCED; DIABETES MELLITUS, TYPE 2; FACTUAL DATABASE; INCIDENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC);

DATABASES, FACTUAL; DIABETES MELLITUS, TYPE 2; GLUCOCORTICOIDS; HUMANS; HYPERGLYCEMIA; INCIDENCE; PREDNISOLONE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84911497884     PISSN: 02506807     EISSN: 14219697     Source Type: Journal    
DOI: 10.1159/000365892     Document Type: Article

References (23)

1. Perez A, Jansen-Chaparro S, Saigi I, Bernal-Lopez MR, Minambres I, Gomez-Huelgas R: Glucocorticoid-induced hyperglycemia. J Diabetes 2014; 6: 9-20.
2. Donihi AC, Raval D, Saul M, Korytkowski MT, DeVita MA: Prevalence and predictors of corticosteroid-related hyperglycemia in hospitalized patients. Endocr Pract 2006; 12: 358-362.
3. Gonzalez-Gonzalez JG, Mireles-Zavala LG, Rodriguez-Gutierrez R, Gomez-Almaguer D, Lavalle-Gonzalez FJ, Tamez-Perez HE, Gonzalez-Saldivar G, Villarreal-Perez JZ: Hyperglycemia related to high-dose glucocorticoid use in noncritically ill patients. Diabetol Metab Syndr 2013; 5: 18.
4. Kwon S, Hermayer KL: Glucocorticoid-induced hyperglycemia. Am J Med Sci 2013; 345: 274-277.
5. Angelopoulos TP, Tentolouris NK, Bertsias GK, Boumpas DT: Steroid-induced diabetes in rheumatologic patients. Clin Exp Rheumatol 2014; 32: 126-130.
6. Tatsuno I, Sugiyama T: Glucocorticoid-induced diabetes mellitus is a risk for vertebral fracture during glucocorticoid treatment. Diabetes Res Clin Pract 2011; 93: E18-e20.
7. Pagano G, Cavallo-Perin P, Cassader M, Bruno A, Ozzello A, Masciola P, Dall'omo AM, Imbimbo B: An in vivo and in vitro study of the mechanism of prednisone-induced insulin resistance in healthy subjects. J Clin Invest 1983; 72: 1814-1820.
8. Rizza RA, Mandarino LJ, Gerich JE: Cortisolinduced insulin resistance in man: Impaired suppression of glucose production and stimulation of glucose utilization due to a postreceptor detect of insulin action. J Clin Endocrinol Metab 1982; 54: 131-138.
9. Abdelmannan D, Tahboub R, Genuth S, Ismail-Beigi F: Effect of dexamethasone on oral glucose tolerance in healthy adults. Endocr Pract 2010; 16: 770-777.
10. Clore JN, Thurby-Hay L: Glucocorticoid-induced hyperglycemia. Endocr Pract 2009; 15: 469-474.
11. Moga C, Guo B, Schopflocher D, Harstall C: Development of a Quality Appraisal Tool for Case Series Studies Using a Modified Delphi Technique. Edmonton, Institute of Health Economics, 2012.
12. McConnell EM, Bell PM, Hadden DR, McCance DR, Sheridan B, Atkinson AB: Prevalence of diabetes and impaired glucose tolerance in adult hypopituitarism on low dose oral hydrocortisone replacement therapy. Clin Endocrinol (Oxf) 2001; 54: 593-599.
13. Ito S, Ogishima H, Kondo Y, Sugihara M, Hayashi T, Chino Y, Goto D, Matsumoto I, Sumida T: Early diagnosis and treatment of steroid-induced diabetes mellitus in patients with rheumatoid arthritis and other connective tissue diseases. Mod Rheumatol 2014; 24: 52-59.
14. Alavi A, Lowe J, Walsh S, Juurlink D, Mortaz-Hedjri S, Shear NH: Corticosteroid-induced hyperglycemia is increased 10-fold in patients with pemphigus. Int J Dermatol 2012; 51: 1248-1252.
15. Udoetuk JD, Dai Y, Ying GS, Daniel E, Gangaputra S, Rosenbaum JT, Suhler EB, Thorne JE, Foster CS, Jabs DA, Levy-Clarke GA, Nussenblatt RB, Kempen JH; Systemic Immunosuppressive Therapy for Eye Diseases Cohort Study Research Group: Risk of corticosteroidinduced hyperglycemia requiring medical therapy among patients with inflammatory eye diseases. Ophthalmology 2012; 119: 1569-1574.
16. Burt MG, Willenberg VM, Petersons CJ, Smith MD, Ahern MJ, Stranks SN: Screening for diabetes in patients with inflammatory rheumatological disease administered longterm prednisolone: A cross-sectional study. Rheumatology (Oxford) 2012; 51: 1112-1119.
17. Ha Y, Lee KH, Jung S, Lee SW, Lee SK, Park YB: Glucocorticoid-induced diabetes mellitus in patients with systemic lupus erythematosus treated with high-dose glucocorticoid therapy. Lupus 2011; 20: 1027-1034.
18. Kim SY, Yoo CG, Lee CT, Chung HS, Kim YW, Han SK, Shim YS, Yim JJ: Incidence and risk factors of steroid-induced diabetes in patients with respiratory disease. J Korean Med Sci 2011; 26: 264-267.
19. Uzu T, Harada T, Sakaguchi M, Kanasaki M, Isshiki K, Araki S, Sugiomoto T, Koya D, Haneda M, Kashiwagi A, Yamauchi A: Glucocorticoid-induced diabetes mellitus: Prevalence and risk factors in primary renal diseases. Nephron Clin Pract 2007; 105: C54-c57.
20. Pilkey J, Streeter L, Beel A, Hiebert T, Li X: Corticosteroid-induced diabetes in palliative care. J Palliat Med 2012; 15: 681-689.
21. Panthakalam S, Bhatnagar D, Klimiuk P: The prevalence and management of hyperglycaemia in patients with rheumatoid arthritis on corticosteroid therapy. Scott Med J 2004; 49: 139-141.
22. Iwamoto T, Kagawa Y, Naito Y, Kuzuhara S, Kojima M: Steroid-induced diabetes mellitus and related risk factors in patients with neurologic diseases. Pharmacotherapy 2004; 24: 508-514.
23. Blackburn D, Hux J, Mamdani M: Quantification of the risk of corticosteroid-induced diabetes mellitus among the elderly. J Gen Intern Med 2002; 17: 717-720.